首页> 外文OA文献 >Molecular determinants of drug-specific sensitivity for epidermal growth factor receptor (EGFR) exon 19 and 20 mutants in non-small cell lung cancer

【2h】

Molecular determinants of drug-specific sensitivity for epidermal growth factor receptor (EGFR) exon 19 and 20 mutants in non-small cell lung cancer

机译：表皮生长因子受体（EGFR）外显子19和20突变体在非小细胞肺癌中的分子决定因素

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Igor F. Tsigelny; Jennifer J. Wheler; Jerry P. Greenberg; Valentina L. Kouznetsova; David J. Stewart; Lyudmila Bazhenova; Razelle Kurzrock;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Association Of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment And EGFR Exon 19 Deletion With Frequency Of The T790M Mutation In Non-Small Cell Lung Cancer Patients After Resistance To First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors [J] . Wen Gao, Jing He, Shi-Dai Jin, OncoTargets and therapy . 2019,第2期

机译：初始表皮生长因子受体酪氨酸激酶抑制剂治疗和EGFR外显子抑制作用的抗T790M突变抗性抗性抗性抗肺癌患者的抗性抗性，抗血疱剂血管生长因子受体酪氨酸激酶激酶抑制剂
2. Cross-Validation Study for Epidermal Growth Factor Receptor and KRAS Mutation Detection in 74 Blinded Non-small Cell Lung Carcinoma Samples: A Total of 5550 Exons Sequenced by 15 Molecular French Laboratories (Evaluation of the EGFR Mutation Status for the Administration of EGFR-TKIs in Non-Small Cell Lung Carcinoma (ERMETIC) Project-Part 1). [J] . Beau Faller M, Rolland E, Antoine M, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2011,第6期

机译：表皮生长因子受体和KRAS突变检测在74个非小细胞肺癌非盲样品中的交叉验证研究：由15个法国分子实验室对总计5550个外显子进行测序（EGFR突变状态在EGFR-TKIs管理中的评估）非小细胞肺癌（ERMETIC）项目-第1部分）。
3. Dynasore-induced potent ubiquitylation of the exon 19 deletion mutant of epidermal growth factor receptor suppresses cell growth and migration in non-small cell lung cancer [J] . Wang Taishu, Wang Duchuang, Zhang Yue, The international journal of biochemistry and cell biology . 2018,第期

机译：EDNASORE诱导的外显子19缺失突变体的表皮生长因子受体的缺失突变体抑制了非小细胞肺癌中的细胞生长和迁移
4. Nanobiophotonics for molecular imaging of cancer: Au- and Ag-based Epidermal Growth Factor receptor (EGFR) specific nanoprobes [C] . Leanne J. Lucas, Kevin C. Hewitt Plasmonics in biology and medicine IX. . 2012

机译：用于癌症分子成像的纳米生物光子学：基于金和银的表皮生长因子受体（EGFR）特定的纳米探针
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. Molecular determinants of drug-specific sensitivity for epidermal growth factor receptor (EGFR) exon 19 and 20 mutants in non-small cell lung cancer [O] . Igor F. Tsigelny, Jennifer J. Wheler, Jerry P. Greenberg, 2015

机译：非小细胞肺癌中表皮生长因子受体（EGFR）外显子19和20突变体的药物特异性敏感性的分子决定因素
7. >Association Of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment And EGFR Exon 19 Deletion With Frequency Of The T790M Mutation In Non-Small Cell Lung Cancer Patients After Resistance To First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors [O] . Wen Gao, Jing He, Shi-Dai Jin, 2019

机译：>初始表皮生长因子受体酪氨酸激酶抑制剂治疗和EGFR外显子抑制剂的抗血液抗性抗血液肺癌患者T790M突变抗性抗性后，抗抗血疱剂患者的抗性，抗抗血管生长因子受体酪氨酸激酶抑制剂

Molecular determinants of drug-specific sensitivity for epidermal growth factor receptor (EGFR) exon 19 and 20 mutants in non-small cell lung cancer

著录项

相似文献

相关主题

期刊订阅